Research statistics
Bremelanotide research: publications and trials
At a glance
Publications, all years
66
Since 2003
Publications in 2026 so far
6
Through November 15, 2026
Human clinical research
25.4%
16 of 63 classified
Registered clinical trials
10
ClinicalTrials.gov
Randomized controlled trials
14
Publications reporting an RCT in people
Systematic reviews and meta-analyses
5
Preclinical studies
15.9%
5 animal · 3 in vitro · 2 computational
Records that only mention it
50
Not counted above
Status in the library: FDA-approved. Groups: Melanocortin agonists. 3 publications are not yet classified by study type.
What to keep in mind
- Some completed trials have neither posted results nor a linked results publication.
Publications by year
Bremelanotide publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|---|
| 2003 | 1 | 0 | 0 | 0 | 1 |
| 2004 | 2 | 1 | 2 | 0 | 5 |
| 2005 | 1 | 0 | 0 | 0 | 1 |
| 2006 | 1 | 0 | 0 | 1 | 2 |
| 2007 | 0 | 1 | 3 | 1 | 5 |
| 2008 | 1 | 0 | 1 | 0 | 2 |
| 2011 | 0 | 0 | 1 | 0 | 1 |
| 2013 | 0 | 0 | 1 | 1 | 2 |
| 2014 | 0 | 0 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 0 | 1 | 2 |
| 2017 | 2 | 0 | 0 | 1 | 3 |
| 2018 | 0 | 0 | 1 | 0 | 1 |
| 2019 | 3 | 0 | 2 | 2 | 7 |
| 2020 | 0 | 2 | 2 | 0 | 4 |
| 2021 | 1 | 1 | 4 | 1 | 7 |
| 2022 | 3 | 0 | 2 | 0 | 5 |
| 2023 | 0 | 0 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 | 0 | 2 |
| 2025 | 0 | 3 | 4 | 0 | 7 |
| 2026 (to date) | 0 | 1 | 4 | 1 | 6 |
Study types
| Review | 26 |
|---|---|
| Randomized controlled trial | 14 |
| Editorial, letter or other | 6 |
| Animal study | 5 |
| In vitro study | 3 |
| Systematic review | 3 |
| Not yet classified | 3 |
| Computational study | 2 |
| Meta-analysis | 2 |
| Other clinical trial | 1 |
| Observational human study | 1 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Reproductive and sexual health | 49 |
|---|---|
| Neurological and mental health | 37 |
| Endocrinology | 3 |
| Dermatology | 2 |
| Metabolic health | 2 |
| Obesity and weight management | 2 |
| Oncology | 2 |
| Antimicrobial and infectious disease | 1 |
| Cardiovascular | 1 |
| Longevity and aging | 1 |
| Tissue repair | 1 |
Registered clinical trials
5 of 9 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.
Completed: 9 · Active, not recruiting: 1
Phase 1: 1 · Phase 2: 4 · Phase 3: 3 · Phase 4: 2
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
- Female Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment Options.
Journal of minimally invasive gynecology · June 19, 2025 · Meta-analysis · cited 6 times
PMID 40543759 · DOI 10.1016/j.jmig.2025.06.004 · Reviews and meta-analyses
- Re-Analyzing Phase III Bremelanotide Trials for "Hypoactive Sexual Desire Disorder" in Women.
Journal of sex research · March 7, 2021 · Meta-analysis · cited 17 times
PMID 33678061 · DOI 10.1080/00224499.2021.1885601 · Reviews and meta-analyses
- Peptides for male sexual dysfunction: a systematic review of emerging evidence.
The journal of sexual medicine · November 1, 2026 · Systematic review · cited 0 times
PMID 43002584 · DOI 10.1093/jsxmed/qdag338 · Reviews and meta-analyses
- Clinical trial evidence on emerging pharmacological therapies for hypoactive sexual desire disorder in women: a systematic review and analysis of completed studies registered on ClinicalTrials.gov.
Frontiers in medicine · May 22, 2026 · Systematic review · cited 0 times · open access
PMID 42254382 · DOI 10.3389/fmed.2026.1789809 · Reviews and meta-analyses
- Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder.
The Annals of pharmacotherapy · January 1, 2020 · Systematic review · cited 47 times
PMID 31893927 · DOI 10.1177/1060028019899152 · Reviews and meta-analyses
- Effect of bremelanotide on body weight of obese women: Data from two phase 1 randomized controlled trials.
Diabetes, obesity & metabolism · March 15, 2022 · Randomized controlled trial · cited 16 times · open access
PMID 35170192 · DOI 10.1111/dom.14672 · Human clinical research
- Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide.
Journal of women's health (2002) · February 25, 2022 · Randomized controlled trial · cited 9 times
PMID 35230162 · DOI 10.1089/jwh.2021.0225 · Human clinical research
- Safety Profile of Bremelanotide Across the Clinical Development Program.
Journal of women's health (2002) · February 1, 2022 · Randomized controlled trial · cited 11 times
PMID 35147466 · DOI 10.1089/jwh.2021.0191 · Human clinical research
- The Patient Experience of Premenopausal Women Treated with Bremelanotide for Hypoactive Sexual Desire Disorder: RECONNECT Exit Study Results.
Journal of women's health (2002) · February 3, 2021 · Randomized controlled trial · cited 12 times
PMID 33538638 · DOI 10.1089/jwh.2020.8460 · Human clinical research
- Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.
Obstetrics and gynecology · November 1, 2019 · Randomized controlled trial · cited 294 times · open access
PMID 31599840 · DOI 10.1097/aog.0000000000003500 · Human clinical research
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.
Obstetrics and gynecology · November 1, 2019 · Randomized controlled trial · cited 294 times · open access
PMID 31599840 · DOI 10.1097/aog.0000000000003500 · Human clinical research
- Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder.
Obstetrics and gynecology · November 1, 2019 · Observational human study · cited 198 times · open access
PMID 31599847 · DOI 10.1097/aog.0000000000003514 · Human clinical research
- Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist.
Proceedings of the National Academy of Sciences of the United States of America · June 28, 2004 · Animal study · cited 129 times · open access
PMID 15226502 · DOI 10.1073/pnas.0400491101 · Animal studies
- Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction.
International journal of impotence research · February 1, 2004 · Randomized controlled trial · cited 128 times
PMID 14963471 · DOI 10.1038/sj.ijir.3901139 · Human clinical research
- An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.
The journal of sexual medicine · July 1, 2006 · Randomized controlled trial · cited 116 times
PMID 16839319 · DOI 10.1111/j.1743-6109.2006.00268.x · Human clinical research
Latest publications
- Peptides for male sexual dysfunction: a systematic review of emerging evidence.
The journal of sexual medicine · November 1, 2026 · Systematic review · cited 0 times
PMID 43002584 · DOI 10.1093/jsxmed/qdag338 · Reviews and meta-analyses
- Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review.
Sexual medicine reviews · September 1, 2026 · Review · cited 0 times
PMID 42862021 · DOI 10.1093/sxmrev/qeag078 · Reviews and meta-analyses
- Comprehensive characterization of bremelanotide acetate and its degradants by LC-HRMS/MS and predicting epimerization through computational modelling.
Analytical methods : advancing methods and applications · August 20, 2026 · Computational study · cited 0 times
PMID 42485063 · DOI 10.1039/d6ay01098a · Computational studies
- Clinical trial evidence on emerging pharmacological therapies for hypoactive sexual desire disorder in women: a systematic review and analysis of completed studies registered on ClinicalTrials.gov.
Frontiers in medicine · May 22, 2026 · Systematic review · cited 0 times · open access
PMID 42254382 · DOI 10.3389/fmed.2026.1789809 · Reviews and meta-analyses
- Should Bremelanotide Be Considered for the Treatment of Sexual Arousal and Desire Disorders in Men?
Journal of clinical psychopharmacology · April 10, 2026 · Not yet classified · cited 0 times
PMID 41960633 · DOI 10.1097/jcp.0000000000002179 · Not yet classified
- Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.
Frontiers in aging · April 7, 2026 · Review · cited 4 times · open access
PMID 42021992 · DOI 10.3389/fragi.2026.1790247 · Reviews and meta-analyses
- Practical considerations and emerging approaches for the management of vasomotor and sexual symptoms in breast cancer patients on endocrine therapies.
Expert review of clinical pharmacology · October 24, 2025 · Review · cited 1 times
PMID 41088800 · DOI 10.1080/17512433.2025.2573780 · Reviews and meta-analyses
- Female Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment Options.
Journal of minimally invasive gynecology · June 19, 2025 · Meta-analysis · cited 6 times
PMID 40543759 · DOI 10.1016/j.jmig.2025.06.004 · Reviews and meta-analyses
- A biodegradable suction patch for sustainable transbuccal peptide delivery.
Journal of controlled release : official journal of the Controlled Release Society · June 11, 2025 · Animal study · cited 7 times · open access
PMID 40513668 · DOI 10.1016/j.jconrel.2025.113947 · Animal studies
- FDA-approved drugs as potential covalent inhibitors of key SARS-CoV-2 proteins: an in silico approach.
Turkish journal of biology = Turk biyoloji dergisi · April 7, 2025 · Computational study · cited 0 times · open access
PMID 40678415 · DOI 10.55730/1300-0152.2741 · Computational studies
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: Bremelanotida; Bremelanotide; Bremelanotidum; PT-141; Vyleesi
((TITLE_ABS:"Bremelanotida" OR CHEM:"Bremelanotida") OR (TITLE_ABS:"Bremelanotide" OR CHEM:"Bremelanotide") OR (TITLE_ABS:"Bremelanotidum" OR CHEM:"Bremelanotidum") OR (TITLE_ABS:"PT-141" OR CHEM:"PT-141" OR TITLE_ABS:"PT141" OR CHEM:"PT141") OR (TITLE_ABS:"Vyleesi" OR CHEM:"Vyleesi")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). Bremelanotide research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/bremelanotide